Drugs and Devices

FDA approves first drug for myelofibrosis

The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease myelofibrosis. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares